Statistical Data
Josef M. Issels, M.D. reported in "Immunotherapy in Progressive Metastatic Cancer, A Fifteen Year Survival Follow-up" Clinical Trials Journal (London) 1970. 7, NO. 3, A Peer Review Paper, pp. 357-366, that of 370 patients with various cancers who were given the Issels Treatment shortly after surgery or irradiation, 322 (87%) were alive and well after five years without relapse or detectable metastases. A restoration of the immune functions can reduce the incidence of relapse from about 50% (World Statistic) to 13% by combined conventional treatments and comprehensive immunotherapy.
John Anderson, M.D., Teaching Professor at King's College Hospital, London, reported 17% cures of histologically verified metastatic malignomas by the Issels Treatment. The independent randomized study comprised 570 patients with various cancers after all conventional methods were exhausted (General Practitioner, March 1971, pp. 15-16, London).
An independent statistical study by A.G. Audier, M.D., University of Leiden, Holland "Immunotherapie Metastasierender Malignome" Die Medizinische 1959, NO. 40, A Peer Review Paper, pp. 1860-64, reported a 16.6% cure rate of histologically verified metastatic malignomas by the Issels Treatment. The study comprised 252 patients with various cancers after all conventional methods were exhausted (world wide cure rate is 2%)
>>> For ADDITIONAL INFORMATION on Treatment and Costs please click here or call 1.888.447.7357
>> Back to top